Depomed Receives Notice of Paragraph IV Certification Against Patents for Gralise(TM)
January 23, 2012 16:30 ET
|
Depomed, Inc.
MENLO PARK, Calif., Jan. 23, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has received a Paragraph IV certification notice from Actavis Elizabeth LLC advising Depomed...
Depomed to Present at Lazard Capital Markets Healthcare Conference
November 08, 2011 16:00 ET
|
Depomed, Inc.
MENLO PARK, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that its president and chief executive officer, Jim Schoeneck, will be presenting at the Lazard Capital...
Depomed Reports Third Quarter 2011 Financial Results
November 01, 2011 16:01 ET
|
Depomed, Inc.
MENLO PARK, Calif., Nov. 1, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today reported financial results for the third quarter ended September 30, 2011 and provided an update on the company's...
Depomed to Announce Third Quarter 2011 Financial Results on Nov. 1, 2011
October 26, 2011 16:00 ET
|
Depomed, Inc.
MENLO PARK, Calif., Oct. 26, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that it will release third quarter 2011 financial results after the market closes on Tuesday, Nov. 1,...
Depomed Announces Top-Line Results From Serada(R) Phase 3 Trial BREEZE 3 in Menopausal Hot Flashes
October 13, 2011 16:00 ET
|
Depomed, Inc.
MENLO PARK, Calif., Oct. 13, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced top-line results from BREEZE 3, a Phase 3 trial evaluating the efficacy and safety of Serada®...
Depomed Announces New Once-Daily GRALISE(TM) Now Available for After-Shingles Pain
October 10, 2011 13:00 ET
|
Depomed, Inc.
MENLO PARK, Calif., Oct. 10, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that GRALISE™ (gabapentin) tablets are now available as a new once-daily treatment for...
Depomed to Present at the UBS Global Life Sciences Conference
September 13, 2011 16:05 ET
|
Depomed, Inc.
MENLO PARK, Calif., Sept. 13, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that its president and chief executive officer, Jim Schoeneck, will be presenting at the UBS Global...
Depomed to Present at the Stifel Nicolaus Healthcare Conference
August 31, 2011 16:05 ET
|
Depomed, Inc.
MENLO PARK, Calif., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that its president and chief executive officer, Jim Schoeneck, will be presenting at the Stifel...
Depomed Reports Second Quarter 2011 Financial Results
August 01, 2011 16:03 ET
|
Depomed, Inc.
MENLO PARK, Calif., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today reported financial results for the second quarter ended June 30, 2011. Total revenues for the quarter were $21.2...
Depomed to Announce Second Quarter 2011 Financial Results on Aug. 1, 2011
July 26, 2011 16:39 ET
|
Depomed, Inc.
MENLO PARK, Calif., July 26, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that it will release second quarter 2011 financial results after the market closes on Monday, Aug. 1,...